Literature DB >> 12584325

Inhibition of adaptive Vgamma2Vdelta2+ T-cell responses during active mycobacterial coinfection of simian immunodeficiency virus SIVmac-infected monkeys.

Dejiang Zhou1, Xiaomin Lai, Yun Shen, Prabhat Sehgal, Ling Shen, Meredith Simon, Liyou Qiu, Dan Huang, George Z Du, Qifan Wang, Norman L Letvin, Zheng W Chen.   

Abstract

Adaptive immune responses of gammadelta T cells during active mycobacterial coinfection of human immunodeficiency virus-infected humans have not been studied. Macaques infected with the simian immunodeficiency virus (SIV) SIVmac were employed to determine the extent to which a coincident AIDS virus infection might compromise immune responses of mycobacterium-specific Vgamma2Vdelta2(+) T cells during active mycobacterial infection. Control SIVmac-negative macaques developed primary and recall expansions of phosphoantigen-specific Vgamma2Vdelta2(+) T cells after Mycobacterium bovis BCG infection and BCG reinfection, respectively. In contrast, SIVmac-infected macaques did not exhibit sound primary and recall expansions of Vgamma2Vdelta2(+) T cells in the blood and pulmonary alveoli following BCG infection and reinfection. The absence of adaptive Vgamma2Vdelta2(+) T-cell responses was associated with profound CD4(+) T-cell deficiency and subsequent development of SIVmac-related tuberculosis-like disease in the coinfected monkeys. Consistently, Vgamma2Vdelta2(+) T cells from coinfected monkeys displayed a reduced capacity to expand in vitro following stimulation with phosphoantigen. The reduced ability of Vgamma2Vdelta2(+) peripheral blood lymphocytes (PBL) to expand could be restored to some extent by coculture of these cells with CD4(+) T cells purified from PBL of SIV-negative monkeys. Furthermore, naïve monkeys inoculated simultaneously with SIVmac and BCG were unable to sustain expansion of Vgamma2Vdelta2(+) T cells at the time that the coinfected monkeys developed lymphoid depletion and a fatal tuberculosis-like disease. Nevertheless, no deletion in Vdelta2 T-cell receptor repertoire was identified in SIVmac-BCG-coinfected macaques, implicating an SIVmac-induced down-regulation rather than a clonal exhaustion of these cells. Thus, an SIVmac-induced compromise of the adaptive Vgamma2Vdelta2(+) T-cell responses may contribute to the immunopathogenesis of the SIV-related tuberculosis-like disease in macaques.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12584325      PMCID: PMC149773          DOI: 10.1128/jvi.77.5.2998-3006.2003

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  46 in total

1.  Recognition of a lipid antigen by CD1-restricted alpha beta+ T cells.

Authors:  E M Beckman; S A Porcelli; C T Morita; S M Behar; S T Furlong; M B Brenner
Journal:  Nature       Date:  1994-12-15       Impact factor: 49.962

2.  Contribution of alpha/beta and gamma/delta T lymphocytes to immunity against Mycobacterium bovis bacillus Calmette Guérin: studies with T cell receptor-deficient mutant mice.

Authors:  C H Ladel; J Hess; S Daugelat; P Mombaerts; S Tonegawa; S H Kaufmann
Journal:  Eur J Immunol       Date:  1995-03       Impact factor: 5.532

3.  Natural and synthetic non-peptide antigens recognized by human gamma delta T cells.

Authors:  Y Tanaka; C T Morita; Y Tanaka; E Nieves; M B Brenner; B R Bloom
Journal:  Nature       Date:  1995-05-11       Impact factor: 49.962

4.  Nonpeptide ligands for human gamma delta T cells.

Authors:  Y Tanaka; S Sano; E Nieves; G De Libero; D Rosa; R L Modlin; M B Brenner; B R Bloom; C T Morita
Journal:  Proc Natl Acad Sci U S A       Date:  1994-08-16       Impact factor: 11.205

5.  CDR3-independent gamma delta V delta 1+ T cell expansion in the peripheral blood of HIV-infected persons.

Authors:  S Boullier; M Cochet; F Poccia; M L Gougeon
Journal:  J Immunol       Date:  1995-02-01       Impact factor: 5.422

6.  Stimulation of human gamma delta T cells by nonpeptidic mycobacterial ligands.

Authors:  P Constant; F Davodeau; M A Peyrat; Y Poquet; G Puzo; M Bonneville; J J Fournié
Journal:  Science       Date:  1994-04-08       Impact factor: 47.728

7.  Polyclonal expansion of peripheral gamma delta T cells in human Plasmodium falciparum malaria.

Authors:  M Ho; P Tongtawe; J Kriangkum; T Wimonwattrawatee; K Pattanapanyasat; L Bryant; J Shafiq; P Suntharsamai; S Looareesuwan; H K Webster; J F Elliott
Journal:  Infect Immun       Date:  1994-03       Impact factor: 3.441

8.  Lymphocytosis of gamma/delta T cells in human ehrlichiosis.

Authors:  C W Caldwell; E D Everett; G McDonald; Y W Yesus; W E Roland
Journal:  Am J Clin Pathol       Date:  1995-06       Impact factor: 2.493

9.  Human V gamma 9-V delta 2 cells are stimulated in a cross-reactive fashion by a variety of phosphorylated metabolites.

Authors:  M R Bürk; L Mori; G De Libero
Journal:  Eur J Immunol       Date:  1995-07       Impact factor: 5.532

10.  T cell receptor V beta repertoire in an acute infection of rhesus monkeys with simian immunodeficiency viruses and a chimeric simian-human immunodeficiency virus.

Authors:  Z W Chen; Z C Kou; C Lekutis; L Shen; D Zhou; M Halloran; J Li; J Sodroski; D Lee-Parritz; N L Letvin
Journal:  J Exp Med       Date:  1995-07-01       Impact factor: 14.307

View more
  22 in total

Review 1.  Vgamma2Vdelta2+ T cells and anti-microbial immune responses.

Authors:  Zheng W Chen; Norman L Letvin
Journal:  Microbes Infect       Date:  2003-05       Impact factor: 2.700

Review 2.  Immune regulation of gammadelta T cell responses in mycobacterial infections.

Authors:  Zheng W Chen
Journal:  Clin Immunol       Date:  2005-09       Impact factor: 3.969

3.  Immune gene networks of mycobacterial vaccine-elicited cellular responses and immunity.

Authors:  Dan Huang; Liyou Qiu; Richard Wang; Xioamin Lai; George Du; Probhat Seghal; Yun Shen; Lingyun Shao; Lisa Halliday; Jeff Fortman; Ling Shen; Norman L Letvin; Zheng W Chen
Journal:  J Infect Dis       Date:  2006-11-22       Impact factor: 5.226

4.  Immune distribution and localization of phosphoantigen-specific Vgamma2Vdelta2 T cells in lymphoid and nonlymphoid tissues in Mycobacterium tuberculosis infection.

Authors:  Dan Huang; Yun Shen; Liyou Qiu; Crystal Y Chen; Ling Shen; Jim Estep; Robert Hunt; Daphne Vasconcelos; George Du; Pyone Aye; Andrew A Lackner; Michelle H Larsen; William R Jacobs; Barton F Haynes; Norman L Letvin; Zheng W Chen
Journal:  Infect Immun       Date:  2007-10-08       Impact factor: 3.441

5.  Only a subset of phosphoantigen-responsive gamma9delta2 T cells mediate protective tuberculosis immunity.

Authors:  Charles T Spencer; Getahun Abate; Azra Blazevic; Daniel F Hoft
Journal:  J Immunol       Date:  2008-10-01       Impact factor: 5.422

Review 6.  Animal models to study Mycobacterium tuberculosis and HIV co-infection.

Authors:  Ming Guo; Wen-Zhe Ho
Journal:  Dongwuxue Yanjiu       Date:  2014-05

7.  Gamma/Delta T cell mRNA levels decrease at mucosal sites and increase at lymphoid sites following an oral SIV infection of macaques.

Authors:  David A Kosub; Andre Durudas; Ginger Lehrman; Jeffrey M Milush; Christopher A Cano; Mamta K Jain; Donald L Sodora
Journal:  Curr HIV Res       Date:  2008-11       Impact factor: 1.581

8.  Gammadelta T cell immune manipulation during chronic phase of simian-human immunodeficiency virus infection [corrected] confers immunological benefits.

Authors:  Zahida Ali; Lin Yan; Nicholas Plagman; Armin Reichenberg; Martin Hintz; Hassan Jomaa; Francois Villinger; Zheng W Chen
Journal:  J Immunol       Date:  2009-09-28       Impact factor: 5.422

9.  Development of Vgamma2Vdelta2+ T cell responses during active mycobacterial coinfection of simian immunodeficiency virus-infected macaques requires control of viral infection and immune competence of CD4+ T cells.

Authors:  Ling Shen; Yun Shen; Dan Huang; Liyou Qiu; Prabhat Sehgal; George Z Du; Michael D Miller; Norman L Letvin; Zheng W Chen
Journal:  J Infect Dis       Date:  2004-09-10       Impact factor: 5.226

Review 10.  Understanding the benign nature of SIV infection in natural hosts.

Authors:  Guido Silvestri; Mirko Paiardini; Ivona Pandrea; Michael M Lederman; Donald L Sodora
Journal:  J Clin Invest       Date:  2007-11       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.